biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1lg-01a-21d-a14k-09
biospecimen_aliquot__bcr_aliquot_uuid	7cdbe0e8-f614-4f54-b864-fd6b39e8ef1c
biospecimen_aliquot__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108476735
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-04-26
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	1
biospecimen_aliquot__plate_id	a14k
biospecimen_aliquot__plate_row	a
biospecimen_aliquot__quantity	4.27
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	53.40
biospecimen_analyte__a260_a280_ratio	1.91
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1lg-01a-21d
biospecimen_analyte__bcr_analyte_uuid	9151eeb0-9451-461b-bab2-ef8402383490
biospecimen_analyte__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1lg
biospecimen_diagnostic_slides__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	8ff0fdd8-e5d5-4ff8-8707-4a760aaa5d36
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1lg
biospecimen_normal_control__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1lg-01a-21
biospecimen_portion__bcr_portion_uuid	cd6a8831-e7c3-4d26-b083-10541bae5b0e
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_portion__date_of_creation	2011-04-05
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1lg-01a-21d
biospecimen_protocol__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_sample__bcr_sample_uuid	b462982a-4dd0-425e-bce3-0eb8f5527264
biospecimen_sample__days_to_collection	252
biospecimen_sample__initial_weight	310
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a1lg.08a790de-b01d-4140-bb1c-b4844291d71e.pdf
biospecimen_sample__pathology_report_uuid	08a790de-b01d-4140-bb1c-b4844291d71e
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	ed36c1d5-f0b6-4ff7-bb8b-34a94cf24075
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	41
biospecimen_shipment_portion__portion_sequence	4
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a1lg-01a-41-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1lg-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1lg-01a-02-tsb
biospecimen_slide__bcr_slide_uuid	23e175ad-93af-41f1-a8be-c37cc3ee5d47
biospecimen_slide__image_file_name	tcga-e2-a1lg-01a-02-tsb.23e175ad-93af-41f1-a8be-c37cc3ee5d47.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	10
biospecimen_slide__percent_tumor_cells	90
biospecimen_slide__percent_tumor_nuclei	95
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1lg
biospecimen_tumor_sample__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
clinical_drug__bcr_drug_barcode	tcga-e2-a1lg-d20669
clinical_drug__bcr_drug_uuid	488371cc-2c95-4257-b1b6-36ab27305123
clinical_drug__bcr_patient_barcode	tcga-e2-a1lg
clinical_drug__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
clinical_drug__form_completion_date	2012-1-17
clinical_drug__pharma_adjuvant_cycles_count	4
clinical_drug__pharmaceutical_therapy_drug_name	cyclophosphamide
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_dose_units	mg
clinical_drug__pharmaceutical_tx_ended_days_to	112
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	70
clinical_drug__pharmaceutical_tx_total_dose_units	mg
clinical_drug__prescribed_dose	1212
clinical_drug__regimen_number	1
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	4848
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1lg-f70390
clinical_follow_up__bcr_followup_uuid	f8b62f0a-6f64-498b-826e-51156ed65f81
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1lg
clinical_follow_up__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2015-3-16
clinical_follow_up__last_contact_days_to	1523
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	no
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-e2-a1lg-o12785
clinical_omf__bcr_omf_uuid	df266125-3af9-42db-b6c1-68b9fdc2d608
clinical_omf__bcr_patient_barcode	tcga-e2-a1lg
clinical_omf__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
clinical_omf__days_to_surgical_resection	-2
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-6-3
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__other_malignancy_histological_type	other, specify
clinical_omf__other_malignancy_histological_type_text	adenoid cystic carcinoma
clinical_omf__other_malignancy_laterality	right
clinical_omf__pathologic_M	m0
clinical_omf__pathologic_N	n0
clinical_omf__pathologic_T	t2
clinical_omf__pathologic_stage	stage iia
clinical_omf__radiation_tx_indicator	no
clinical_omf__system_version	7th
clinical_patient__age_at_diagnosis	50
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n0
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	axillary lymph node dissection alone
clinical_patient__bcr_patient_barcode	tcga-e2-a1lg
clinical_patient__bcr_patient_uuid	ef4cbd38-bc79-4d60-a715-647edd2ebe9e
clinical_patient__birth_days_to	-18492
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 0+0 = 0
clinical_patient__er_positivity_scale_other	allred score = 0
clinical_patient__er_status_by_ihc	negative
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-6-3
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.1
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	60-69%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	350
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	19
clinical_patient__lymph_nodes_examined_he_count	0
clinical_patient__margin_status	negative
clinical_patient__menopause_status	peri (6-12 months since last menstrual period)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1lg
clinical_patient__pr_positivity_define_method	allred score 0+0 = 0
clinical_patient__pr_positivity_scale_other	allred score = 0
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1LG-01A-21D-A14K-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1LG-01A-21D-A14K-09.bed.meta
manually_curated__id	tcga-e2-a1lg-01a-21d-a14k-09
manually_curated__md5sum	93fb523f525e14a49bf88c6e8a1c1bb4
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	7cdbe0e8-f614-4f54-b864-fd6b39e8ef1c
manually_curated__tumor_tag	brca
